Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery
The Long Run with Luke Timmerman
00:00
How Did You See the Potential in China?
Sang Ahta is the founder and CEO of a company that converts biologics to small molecules. He went on sabatical in shanghai, china with two students who were becoming professors there. Sang: "I was actually curious about how drug discovery health care was going to evolve in ch China"
Transcript
Play full episode
